Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)
Close on Nov 17, 2026Market cap $424.04MP/E –Yield –
Prothena Corp Public operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Prothena Corp Public's operating income for the twelve months ending Jun 30, 2026 was -$55.51M. For fiscal 2025 it was -$214.64M. The highest annual figure on record is $71.98M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$214.64M | – |
| FY2024 | Dec 31, 2024 | -$154.56M | – |
| FY2023 | Dec 31, 2023 | -$191.04M | – |
| FY2022 | Dec 31, 2022 | -$131.56M | -282.8% |
| FY2021 | Dec 31, 2021 | $71.98M | – |
| FY2020 | Dec 31, 2020 | -$112.73M | – |
| FY2019 | Dec 31, 2019 | -$85.70M | – |
| FY2018 | Dec 31, 2018 | -$158.86M | – |
| FY2017 | Dec 31, 2017 | -$155.25M | – |
| FY2016 | Dec 31, 2016 | -$159.54M | – |
| FY2015 | Dec 31, 2015 | -$79.94M | – |
| FY2014 | Dec 31, 2014 | -$6.65M | – |
| FY2013 | Dec 31, 2013 | -$40.43M | – |
| FY2012 | Dec 31, 2012 | -$41.41M | – |
| FY2011 | Dec 31, 2011 | -$29.24M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$21.10M | – |
| Q1 FY2026 | Mar 31, 2026 | $30.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$24.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$40.24M | – |
| Q2 FY2025 | Jun 30, 2025 | -$84.62M | -244.9% |
| Q1 FY2025 | Mar 31, 2025 | -$65.58M | – |
| Q4 FY2024 | Dec 31, 2024 | -$64.90M | – |
| Q3 FY2024 | Sep 30, 2024 | -$66.51M | -745.3% |
| Q2 FY2024 | Jun 30, 2024 | $58.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$81.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$78.52M | – |
| Q3 FY2023 | Sep 30, 2023 | $10.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -$66.50M | – |
| Q1 FY2023 | Mar 31, 2023 | -$56.33M | – |
| Q4 FY2022 | Dec 31, 2022 | -$72.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$50.33M | -146.1% |
| Q2 FY2022 | Jun 30, 2022 | -$43.21M | -254.6% |
| Q1 FY2022 | Mar 31, 2022 | -$37.94M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.09M | – |
| Q3 FY2021 | Sep 30, 2021 | $109.23M | – |
| Q2 FY2021 | Jun 30, 2021 | $27.95M | – |
| Q1 FY2021 | Mar 31, 2021 | -$32.11M | – |
| Q4 FY2020 | Dec 31, 2020 | -$30.31M | – |
| Q3 FY2020 | Sep 30, 2020 | -$30.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$26.73M | – |
| Q1 FY2020 | Mar 31, 2020 | -$24.85M | – |
| Q4 FY2019 | Dec 31, 2019 | -$23.27M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.97M | – |
| Q2 FY2019 | Jun 30, 2019 | -$18.50M | – |
| Q1 FY2019 | Mar 31, 2019 | -$22.95M | – |
| Q4 FY2018 | Dec 31, 2018 | -$22.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$24.32M | – |
| Q2 FY2018 | Jun 30, 2018 | -$63.07M | – |
| Q1 FY2018 | Mar 31, 2018 | -$48.71M | – |
| Q4 FY2017 | Dec 31, 2017 | -$47.32M | – |
| Q3 FY2017 | Sep 30, 2017 | -$53.53M | – |
| Q2 FY2017 | Jun 30, 2017 | -$18.13M | – |
| Q1 FY2017 | Mar 31, 2017 | -$36.27M | – |
| Q4 FY2016 | Dec 31, 2016 | -$49.28M | – |
| Q3 FY2016 | Sep 30, 2016 | -$42.69M | – |
See a number that looks wrong?